文献速递生殖医学

辅助生殖治疗队列研究中因未同意导致的偏倚:人类受精与胚胎学管理局登记库中非接触研究披露同意的分析

Bias due to non-consent in assisted reproductive treatment cohort studies: consent for disclosure to non-contact research in the Human Fertilisation and Embryology Authority register.
PubMed 文献 · Hum Reprod · 2025-01-01

该队列研究利用英国人类受精与胚胎学管理局(HFEA)2004至2018年全部自体辅助生殖治疗周期(n=819 512)及155 986例单胎活产数据,分析患者同意披露信息(CD)与人群特征及结局的关系。结果显示CD率从2009年的16%升至2018年的64%,CD组与非CD组人群特征分布不同,CD与活产率及低出生体重相关。作者认为仅使用同意数据可能产生偏倚,提出可按同意概率加权校正。

要点

  • CD率从2009年的16%上升至2018年的64%。
  • 高龄(40-44岁)及少数族裔(黑人和亚洲人)周期给予CD较少。
  • CD组活产率较高,非CD组低出生体重略更常见。

核心结论

  • 仅使用同意数据可能使辅助生殖观察性队列研究的样本不同于未同意样本及一般辅助生殖人群,未考虑同意的影响很可能产生误导性结果。

研究设计与样本

  • 队列研究,使用英国人类受精与胚胎学管理局(HFEA)2004至2018年全部CD和非CD自体辅助生殖治疗周期(n=819 512)的匿名数据集。
  • 活产子集为同期出生的155 986例单胎,用于分析儿童结局。
  • 另使用HFEA聚合数据按诊所类型(国家卫生服务体系[NHS]、私立或两者兼有)探索CD趋势。

主要发现

  • 研究期间CD率从2009年开始时的16%上升至2018年的64%。
  • 高龄(40-44岁)和少数族裔(黑人和亚洲人)的周期给予CD较少;有既往辅助生殖治疗和活产史的周期CD率较低。
  • CD与活产率相关(CD组较高),低出生体重在非CD组略更常见。
  • 仅NHS资助诊所的CD率始终高于部分或完全私人资助的诊所。

关键数值与推荐

  • 低出生体重定义为出生体重<2500 g,巨大儿定义为出生体重≥4000 g。
  • 所有回归模型均调整潜在混杂因素:母亲年龄、种族、既往IVF周期、既往妊娠、既往活产、不孕原因(输卵管、子宫内膜异位症、男方因素、排卵、不明原因)、胚胎移植类型和阶段。
  • 活产和出生体重模型额外调整ICSI、选择性单胚胎移植和卵巢刺激;出生体重模型还调整儿童性别和孕周。

临床怎么用

  • 作者认为,在分析和解释HFEA登记库及其他类似队列数据时需谨慎关注同意的影响。
  • 作者指出,在HFEA登记库中,这适用于2009年10月引入CD后使用CD数据的研究(包括定制数据请求和链接研究)。
  • 作者简要介绍了按同意概率加权的一种潜在解决方案。

局限性

  • 数据集未提供或无法获得的重要因素包括社会经济和生活方式因素。
  • 提供给作者的匿名数据集母亲年龄、孕周和出生体重变量为分带/分类变量,可能限制估计的精确度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is patient consent to research associated with the distribution of population characteristics and study outcomes in ART cohort studies? SUMMARY ANSWER: The distribution of population characteristics in the patient consent subset differs from that in the non-consent subset and is not fully representative of the general ART population; thus, study results of population subsets requiring patient consent may be subject to bias. WHAT IS KNOWN ALREADY: Non-consent in epidemiological studies may bias study results if the consent subset differs systematically from the non-consent subset and is thus not representative of the full study population. ART cohort datasets may be biased if they require patients to consent to use their data. As an example, from September 2009 onwards, ART patients in the UK have been asked for specific 'consent to disclosure of identifying information' (CD) for research studies. STUDY DESIGN, SIZE, DURATION: This cohort study utilized an anonymized version of the Human Fertilisation and Embryology Authority (HFEA) dataset containing all CD and non-CD autologous ART treatment cycles (n = 819 512) conducted from 2004 to 2018 in the UK. A live birth (LB) subset of 155 986 singletons born during the same period was used to analyse child outcomes. Additionally, an aggregated version of the HFEA dataset was used to explore CD trends by clinic type (National Health Service [NHS], private, or both NHS and privately funded). PARTICIPANTS/MATERIALS, SETTING, METHODS: The dataset containing all gamete cycles was used to explore factors associated with giving CD and to compare LB outcome trends (number of LBs per yearly treatment cycles started) between CD and non-CD cycles. The LB subset was used to compare the birthweight outcomes (low birthweight (LBW = birthweight < 2500 g or otherwise) and macrosomia (birthweight ≥4000 g or otherwise)) between CD and non-CD cycles. Logistic regression models explored the association between CD and population characteristics and the impact of CD on birthweight outcomes over the calendar years. Each regression model was adjusted for potential confounders: for all models (maternal age, ethnicity, previous IVF cycles, previous pregnancies, previous LBs, causes of infertility (tubal, endometriosis, male factor, ovulatory, unknown), and embryo transfer type and stage); for LB and birthweight models (ICSI, elective single embryo transfer, and ovarian stimulation); and additionally for birthweight models (child sex and gestation). MAIN RESULTS AND THE ROLE OF CHANCE: During the study period, CD rates increased from 16% at its inception in 2009 to 64% in 2018. Fewer cycles from older patients (40-44 years old) and ethnic minorities (Black and Asian) gave CD. Cycles with previous ART treatments and LBs had lower rates of giving CD. CD was also associated with LB rates (higher in the CD group) and LBW (slightly more prevalent in the non-CD group). CD rates were consistently higher in NHS-only funded clinics than in clinics with partly or fully private funding. It may be possible to adjust for much of the post-2009 bias by weighting by the probability of inclusion derived from supplementary data. LIMITATIONS, REASONS FOR CAUTION: Important factors not provided or unavailable in the dataset included socio-economic and lifestyle factors. Additionally, the anonymized dataset provided to us had banded/categorized maternal age, gestation, and birthweight variables, possibly limiting our estimates' precision. WIDER IMPLICATIONS OF THE FINDINGS: This study shows that using only consented data in ART observational cohort studies may result in a sample that differs from the non-consented sample and general ART population. Specifically, our results show differences in the distribution of population characteristics, LB, and LBW outcomes between CD and non-CD groups in the UK HFEA ART register dataset. Careful attention is therefore required when analysing and interpreting these and similar cohort data; failure to consider the impact of consent will likely produce misleading results. In the HFEA register, this applies to research studies using CD data (including bespoke data requests and linkage studies) after the introduction of CD in October 2009. A potential solution weighting by the probability of consent is briefly introduced. STUDY FUNDING/COMPETING INTEREST(S): This study was funded by the EU H2020 Marie Sklodowska-Curie Innovative Training Networks (ITN) grant Dohartnet (H2020-MSCA-ITN-2018-812660). The authors have no competing interests to declare. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Kondowe FJM, Gittins M, Clayton P, et al. Bias due to non-consent in assisted reproductive treatment cohort studies: consent for disclosure to non-contact research in the Human Fertilisation and Embryology Authority register. Hum Reprod. 2025. PMID: 40121691. doi:10.1093/humrep/deaf045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。